Satralizumab

ATC L04AC19 · 10 markets · 11 records

Satralizumab 10 markets · 11 records Forms

AU 2 records · 2 strengths

  • 120 mginjectionENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe also in US·ES·TW unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 1 records · 1 strengths

GB 1 records · 1 strengths

  • 120 mg/1 mLinjectionEnspryng 120mg/1ml solution for injection pre-filled syringes also in FR

CA 1 records · 1 strengths

SG 1 records · 1 strengths

  • 120 mg/mLinjectionENSPRYNG SOLUTION FOR INJECTION IN PREFILLED SYRINGE 120MG/1ML

ES 1 records · 1 strengths

TW 1 records · 1 strengths

HK 1 records · 1 strengths

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名ENSPRYNG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 120MG/1ML ×1

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

      FR 1 records · 1 strengths

      • 120 mg/1 mLinjectionENSPRYNG 120 mg, solution injectable en seringue préremplie also in GB

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.